PSI CRO Further Strengthens Capabilities in Infectious Diseases Clinical Trials

ICAAC 2014

ZUG, Switzerland--()--PSI CRO, a full-service contract research organization, mentioned today that they are strengthening their clinical trial management approaches in the area of Infectious Diseases.

A therapeutically aligned infectious diseases team will support all ID studies at PSI, focused to provide optimized approaches to patient enrollment. The team will include staff from various departments including Feasibility, Medical Affairs and Project Management.

PSI has continued to grow their Infectious Diseases experience that includes new and ongoing global studies in pneumonias, complicated urinary tract infections, intra-abdominal infections, skin infections, sepsis, and other indications. In the recent weeks, PSI reached an interim enrollment objective of several hundred patients in a global community acquired pneumonia trial, completed a global trial in a complicated urinary tract infection trial, fully enrolled a Phase III intra-abdominal infection study, as well as a trial of an influenza vaccine.

PSI will be represented at ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) at Booth 514 that will be held in Washington D.C. on Saturday, September 6th through Monday, September 8th at the Walter E. Washington Convention Center.

About PSI CRO AG: PSI is a Swiss-based privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com

Contacts

PSI Inquiries to:
PSI CRO AG
Barbara Breen, +1 847-202-1120
Marketing@psi-cro.com

Release Summary

PSI CRO, a global full-service contract research organization, are further strengthening their clinical trial management approaches in the area of Infectious Diseases.

Contacts

PSI Inquiries to:
PSI CRO AG
Barbara Breen, +1 847-202-1120
Marketing@psi-cro.com